Induction Chemotherapy with Docetaxel, Cisplatin and Capecitabine, Followed by Combined Cetuximab and Radiotherapy in Patients with Locally Advanced Inoperable Head and Neck Cancer. Preliminary Results of a Phase I/II Study

被引：1
|
作者：
Perri, F. [1 ]
Muto, P. [1 ]
Schiavone, C. [1 ]
Ionna, F. [1 ]
Aversa, C. [1 ]
Maiolino, P. [1 ]
Cavalcant, E. [1 ]
Sandomenico, F. [1 ]
Caponigro, F. [1 ]
机构：
[1] Natl Tumor Inst Naples, Naples, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
10.1016/S0959-8049(12)72380-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
583
引用
收藏
页码：178 / 179
页数：2
相关论文
共 50 条
  • [1] Induction Chemotherapy with Docetaxel, Cisplatin and Capecitabine, Followed by Combined Cetuximab and Radiotherapy in Patients with Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck: A Phase I-II Study
    Perri, Francesco
    Muto, Paolo
    Argenone, Angela
    Ionna, Franco
    Longo, Francesco
    Fulciniti, Franco
    Sandomenico, Fabio
    Daponte, Antonio
    Caponigro, Francesco
    [J]. ONCOLOGY, 2013, 84 (04) : 251 - 254
  • [2] Induction Docetaxel, Cisplatin, and Cetuximab Followed by Concurrent Radiotherapy, Cisplatin, and Cetuximab and Maintenance Cetuximab in Patients With Locally Advanced Head and Neck Cancer
    Argiris, Athanassios
    Heron, Dwight E.
    Smith, Ryan P.
    Kim, Seungwon
    Gibson, Michael K.
    Lai, Stephen Y.
    Branstetter, Barton F.
    Posluszny, Donna M.
    Wang, Lin
    Seethala, Raja R.
    Dacic, Sanja
    Gooding, William
    Grandis, Jennifer R.
    Johnson, Jonas T.
    Ferris, Robert L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (36) : 5294 - 5300
  • [3] Induction capecitabine and cisplatin followed by hypofractionated radiotherapy in locally advanced head and neck cancer.
    Hashmi, Quratul Ain
    Mateen, Abdul
    Khan, Muhammad Saqib
    Adil, Allah Rakha
    Duraishi, Arif Moin
    Abdullah, Famya
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Induction chemotherapy with docetaxel, cisplatin and cetuximab versus docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced or inoperable squamous cell carcinoma of the head and neck: Promising results of a randomized phase II AGMT-trial.
    Keil, Felix
    Hartl, Maximilian
    Altorjai, Gabriela
    Pecherstorfer, Martin
    Mayrbaeurl, Beate
    de Vries, Alexander
    Berghold, Andrea
    Riedl, Regina
    Fridrik, Michael A.
    Fuereder, Thorsten
    Burian, Martin
    Greil, Richard
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] A Randomized, Multicenter, Phase II Study of Cetuximab With Docetaxel and Cisplatin as Induction Chemotherapy in Unresectable, Locally Advanced Head and Neck Cancer
    Lee, Keun-Wook
    Koh, Youngil
    Kim, Sung-Bae
    Shin, Sang-Won
    Kang, Jin-Hyoung
    Wu, Hong-Gyun
    Sung, Myung-Whun
    Keam, Bhumsuk
    Kim, Dong-Wan
    Kim, Tae Min
    Km, Kwang Hyun
    Kwon, Tack-Kyun
    Hah, J. Hun
    Kim, In-Ah
    Ahn, Soon-Hyun
    Yoon, Dok Hyun
    Lee, Sang-Wook
    Kim, Sang Yoon
    Nam, Soon Yuhl
    Jung, Kwang-Yoon
    Baek, Seung-Kuk
    Hong, Sock Hee
    Lee, Se-Hoon
    Heo, Dae Seog
    [J]. ONCOLOGIST, 2015, 20 (10): : 1119 - 1120
  • [6] A phase II trial of induction chemotherapy with docetaxel/capecitabine (DC) for patients with locally advanced head and neck cancer
    Yun, Hwan-Jung
    Kim, Jin-Man
    Song, Chang-June
    Park, Seok-Won
    Roh, Jong-Lyel
    Park, Keon-Uk
    Shin, Yousik
    Jo, Deog-Yeon
    Kim, Samyong
    Cho, Moon-June
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 138 - 139
  • [7] Update of a phase II trial of induction chemotherapy with docetaxel/capecitabine (DC) for patients with locally advanced head and neck cancer
    Yang, Y. J.
    Yun, G. W.
    Lee, I. H.
    Kim, S. M.
    Kim, J. M.
    Yoon, Y. H.
    Koo, B. S.
    Cho, M. J.
    Kim, S. Y.
    Yun, H. J.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 492 - 492
  • [8] First Results of an Uncontrolled, Phase II Trial of Induction Chemotherapy With Cetuximab and Docetaxel-Cisplatin-5FU Followed by Cetuximab plus Radiotherapy in the Responders in Locally Advanced Resectable Squamous Cell Cancer of the Head and Neck
    Remenar, E.
    Loevey, J.
    Koltai, P.
    Horvath, K.
    Goedeny, M.
    Kasler, M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S553 - S553
  • [9] Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck
    Keil, F.
    Selzer, E.
    Berghold, A.
    Reinisch, S.
    de Vries, A.
    Greil, R.
    Bachtiary, B.
    Tinchon, C.
    Anderhuber, W.
    Burian, M.
    Kasparek, A. K.
    Elsaesser, W.
    Kainz, H.
    Riedl, R.
    Kapp, K.
    Kopp, M.
    Kornek, G.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 273 - 273
  • [10] INDUCTION CHEMOTHERAPY WITH DOCETAXEL, CISPLATIN AND 5-FLUOROURACIL FOLLOWED BY RADIOTHERAPY WITH CETUXIMAB FOR LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
    Keil, F.
    Selzer, E.
    Berghold, A.
    Kapp, K.
    De Vries, A.
    Greil, R.
    Reinisch, S.
    Anderhuber, W.
    Burian, M.
    Kornek, G. V.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 340 - 341
12345